Gonadotropin-releasing hormone agonist use in men without a cancer registry diagnosis of prostate cancer.

Kuo YF, Goodwin JS, Shahinian VB. Gonadotropin-releasing hormone agonist use in men without a cancer registry diagnosis of prostate cancer. BMC Health Serv Res. 2008 Jul 14; 8:146.

View in: PubMed

subject areas

Aged
Comorbidity
Educational Status
Gonadotropin-Releasing Hormone
Humans
Insurance Claim Review
Logistic Models
Male
Medicare
Prostatic Neoplasms
SEER Program
United States

authors with profiles

J Shawn Goodwin

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support